Save on Daratumumab And Hyaluronidase-FIHJ with Coupons, Discounts & Savings Programs

Daratumumab And Hyaluronidase-FIHJ is available as a single dose vial containing 1,800 mg of daratumumab and 30,000 units of hyaluronidase per 15 mL.

Daratumumab And Hyaluronidase-FIHJ is a combination medication used to treat multiple myeloma and light chain amyloidosis in adults.

Daratumumab And Hyaluronidase-FIHJ contains 2 medications:

• Daratumumab is an anti-CD38 monoclonal antibody. It treats multiple myeloma and light chain amyloidosis by targeting a specific protein called CD38 on the plasma cells’ surface. By binding to this protein, daratumumab attacks and kills the abnormal cells, and also signals to the immune system to do the same.
• Hyaluronidase is an endoglycosidase. It works by helping the active medication (daratumumab) get absorbed under the skin.

The recommended dosage of Daratumumab And Hyaluronidase-FIHJ is (1,800 mg daratumumab and 30,000 units hyaluronidase) given subcutaneously into the abdomen over around 3 to 5 minutes according to recommended schedule. You should be pre-medicated with a corticosteroid, acetaminophen and a histamine-1 receptor antagonist prior to the injection.

Daratumumab And Hyaluronidase-FIHJ is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication in the following:

• History of severe hypersensitivity to daratumumab,
• Hyaluronidase or any of the components of the formulation

Common side effects of Daratumumab And Hyaluronidase-FIHJ:

• Decreased red blood cell counts
• Tiredness
• Trouble sleeping
• Headache
• Fever
• Cough
• Shortness of breath
• Nausea, vomiting
• Rash
• Muscle spasms
• Back pain
• High blood pressure
• Muscle, bone, and joint pain
• Cold-like symptoms
• Nerve damage
• Constipation or diarrhea
• Lung infection

Serious side effects are rare with Daratumumab And Hyaluronidase-FIHJ. Contact your healthcare provider immediately if you experience any of the following:

• Serious reaction during infusion: shortness of breath or trouble breathing, dizziness or lightheadedness, cough, wheezing, heart beating faster than usual, throat tightness or irritation, runny or stuffy nose, headache, itching, high blood pressure, eye pain, nausea, vomiting, chills, fever, chest pain, blurred vision
• Serious infections (from low white blood cell levels): fever, headache, sore throat, cough, body aches, chills, weakness, tiredness
• Serious bleeds (from low platelet count): bruising that won’t go away or bleeding that’s difficult to stop
• Heart problems (in people with amyloidosis): feeling faint, trouble breathing, swollen legs, chest pain, abnormal heart rhythm

There are no major drug interactions listed for this medication. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.

Various FDA-approved generic manufacturers

Daratumumab And Hyaluronidase-FIHJ may harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment. Females who can get pregnant should use an effective method of birth control (contraception) during treatment and for 3 months after your last dose.

• Darzalex Faspro